Evidence map›Paper›PMID 34501278›Full record

ArticleJournal of clinical medicine2021

Importance of In-Hospital Prospective Registry and Infectious Endocarditis Heart Team to Monitor and Improve Quality of Care in Patients with Infectious Endocarditis.

Guy Van Camp, Monika Beles, Martin Penicka, Dan Schelfaut, Stijn Wouters, Herbert De Raedt, Eric Wyffels, Jerrold Spapen, Riwa Nasser, Zsuzsanna Balogh and 8 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Infective endocarditis: it takes a team.European heart journal · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 3 countries.

Guy Van CampCardiovascular Center, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.ORCID 0000-0002-9815-8337
Monika BelesCardiovascular Center, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
Martin PenickaCardiovascular Center, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
Dan SchelfautCardiovascular Center, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
Stijn WoutersCardiovascular Center, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
Herbert De RaedtCardiovascular Center, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
Eric WyffelsCardiovascular Center, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
Jerrold SpapenCardiovascular Center, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
Riwa NasserCardiovascular Center, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
Zsuzsanna BaloghGottsegen Gyorgy National Institute of Cardilogy, Haller u. 29, 1096 Budapest, Hungary.
Marzia AlbanoCardiology Unit, S. Maria Nuova Hospital, Via Amendola 2, 42122 Reggio Emilia, Italy.
Hans De BeenhouwerDepartment of Microbiology, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
Kristien Van VaerenberghDepartment of Microbiology, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
Frank Van PraetCardiovascular and Thoracic Surgery, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
Ivan DegrieckCardiovascular and Thoracic Surgery, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
Bernard StockmanCardiovascular and Thoracic Surgery, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
Filip CasselmanCardiovascular and Thoracic Surgery, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
Carlos ColletCardiovascular Center, OLV Aalst, Moorselbaan 164, 9300 Aalst, Belgium.
Onze Lieve Vrouwziekenhuis Hospital · BEGottsegen National Cardiovascular Center · HUSanta Maria Nuova Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the value of prospective in-hospital registry data and the impact of an infectious endocarditis heart team approach (IEHT) on improvement in quality of care and monitor outcomes in hospitalized patients with IE.

methodsBetween December 2014 and the end of 2019, 160 patients were hospitalized in one centre with the definite diagnosis of infectious endocarditis (IE) and entered in a prospective registry. From 2017, an IEHT was introduced. Propensity score matching was used to assess the impact of an IEHT approach on clinical outcomes.

resultsMedian age was 72.5 y (62.75-80.00), diabetes was present in 33.1%, chronic kidney disease in 27.5%, COPD in 17.5%, and a history of ischaemic heart disease in 30.6%. Prosthetic valve IE was observed in 43.8% and device-related IE in 16.9% of patients. Staphylococcus (37.5%) was the most frequent pathogen followed by streptococcus (24.4%) and enterococcus (23.1%). Overall, 30-day and 1-year mortality were 19.4% and 37.5%, respectively. The introduction of prospective data collection and IE heart team was associated with a trend towards reduction of adjusted 1-year mortality (26.5% IEHT vs. 41.2% controls,

conclusionsUse of a prospective registry of IE coupled with a heart team approach was associated with more efficient patient management and a trend towards lower mortality. Prospective data collection and dedicated IEHT have the potential to improve patient care and clinical outcomes.

Indexed as

infectious endocarditisoutcomequality of care

Identifiers

PMID34501278
PMCPMC8432016
OpenAlexW3195804273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.